Product NDC: | 0591-0800 |
Proprietary Name: | Hydroxyzine Pamoate |
Non Proprietary Name: | Hydroxyzine Pamoate |
Active Ingredient(s): | 25 mg/1 & nbsp; Hydroxyzine Pamoate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0591-0800 |
Labeler Name: | Watson Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040156 |
Marketing Category: | ANDA |
Start Marketing Date: | 19960715 |
Package NDC: | 0591-0800-01 |
Package Description: | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-0800-01) |
NDC Code | 0591-0800-01 |
Proprietary Name | Hydroxyzine Pamoate |
Package Description | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-0800-01) |
Product NDC | 0591-0800 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydroxyzine Pamoate |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19960715 |
Marketing Category Name | ANDA |
Labeler Name | Watson Laboratories, Inc. |
Substance Name | HYDROXYZINE PAMOATE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antihistamine [EPC],Histamine Receptor Antagonists [MoA] |